36 results on '"Westphal, Koen G."'
Search Results
2. Synthesis and Evaluation of Polymyxins Bearing Reductively Labile Disulfide-Linked Lipids
- Author
-
Slingerland, Cornelis J., Wesseling, Charlotte M. J., Innocenti, Paolo, Westphal, Koen G. C., Masereeuw, Rosalinde, Martin, Nathaniel I., Afd Chemical Biology and Drug Discovery, Afd Pharmacology, Chemical Biology and Drug Discovery, Pharmacology, Afd Chemical Biology and Drug Discovery, Afd Pharmacology, Chemical Biology and Drug Discovery, and Pharmacology
- Subjects
Accumulation ,Antibiotics ,Colistin ,Gram-negative bacteria ,Drug Discovery ,Kidney injury ,Molecular Medicine ,Antimicrobial activity ,Nephrotoxicity ,Components ,Derivatives ,Nonapeptide - Abstract
Polymyxins are a class of lipopeptide anti-infective agents with potent and specific activity against Gram-negative bacteria. While toxicity concerns associated with polymyxin B and E (colistin) have historically limited their clinical application, today they are increasingly used as last-resort antibiotics given the rise of multidrug-resistant Gram-negative pathogens. The adverse side effects of polymyxins are well known, particularly as related to their nephrotoxicity. Here, we describe the synthesis and evaluation of a novel series of polymyxin analogues, aimed at reducing their nephrotoxic effects. Using a semisynthetic approach, we explored modifications of the exocyclic part of the polymyxin scaffold, namely, the terminal amino acid and lipophilic tail. By incorporating a reductively labile disulfide linkage in the lipid tail, we obtained novel polymyxins that exhibit potent antibacterial activity on par with polymyxin B but with reduced toxicity toward human renal proximal tubular epithelial cells.
- Published
- 2022
3. Synthesis and Evaluation of Polymyxins Bearing Reductively Labile Disulfide-Linked Lipids
- Author
-
Afd Chemical Biology and Drug Discovery, Afd Pharmacology, Chemical Biology and Drug Discovery, Pharmacology, Slingerland, Cornelis J., Wesseling, Charlotte M. J., Innocenti, Paolo, Westphal, Koen G. C., Masereeuw, Rosalinde, Martin, Nathaniel I., Afd Chemical Biology and Drug Discovery, Afd Pharmacology, Chemical Biology and Drug Discovery, Pharmacology, Slingerland, Cornelis J., Wesseling, Charlotte M. J., Innocenti, Paolo, Westphal, Koen G. C., Masereeuw, Rosalinde, and Martin, Nathaniel I.
- Published
- 2022
4. Minocycline restores spatial but not fear memory in olfactory bulbectomized rats
- Author
-
Borre, Yuliya, Sir, Volkan, de Kivit, Sander, Westphal, Koen G., Olivier, Berend, and Oosting, Ronald S.
- Published
- 2012
- Full Text
- View/download PDF
5. Akt1 Deficiency Affects Neuronal Morphology and Predisposes to Abnormalities in Prefrontal Cortex Functioning
- Author
-
Lai, Wen-Sung, Xu, Bin, Westphal, Koen G. C., Paterlini, Marta, Olivier, Berend, Pavlidis, Paul, Karayiorgou, Maria, and Gogos, Joseph A.
- Published
- 2006
- Full Text
- View/download PDF
6. The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats
- Author
-
Prins, Jolanda, Denys, Damiaan A., Westphal, Koen G., Korte-Bouws, Gerdien A., Quinton, Maria S., Schreiber, Rudy, Groenink, Lucianne, Olivier, Berend, and Korte, S. Mechiel
- Published
- 2010
- Full Text
- View/download PDF
7. The many different faces of major depression: It is time for personalized medicine
- Author
-
Korte, Mechiel S., Prins, Jolanda, Krajnc, Anne M., Hendriksen, Hendrikus, Oosting, Ronald S., Westphal, Koen G., Korte-Bouws, Gerdien A.H., and Olivier, Berend
- Published
- 2015
- Full Text
- View/download PDF
8. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice
- Author
-
Paterlini, Marta, Zakharenko, Stanislav S, Lai, Wen-Sung, Qin, Jie, Zhang, Hui, Mukai, Jun, Westphal, Koen G C, Olivier, Berend, Sulzer, David, Pavlidis, Paul, Siegelbaum, Steven A, Karayiorgou, Maria, and Gogos, Joseph A
- Published
- 2005
- Full Text
- View/download PDF
9. Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration
- Author
-
Borre, Yuliya, Bosman, Esmeralda, Lemstra, Susan, Westphal, Koen G., Olivier, Berend, and Oosting, Ronald S.
- Published
- 2012
- Full Text
- View/download PDF
10. The 5-HT1A/1B-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and 'waiting' impulsivity, but increases 'stopping' impulsivity
- Author
-
Korte, S Mechiel, Prins, Jolanda, Van den Bergh, Filip S, Oosting, Ronald S, Dupree, Rudy, Korte-Bouws, Gerdien A H, Westphal, Koen G C, Olivier, Berend, Denys, Damiaan A, Garland, Alexis, Güntürkün, Onur, Pharmacology, Afd Pharmacology, Sub Onderwijsinstituut Farmacie, Pharmacology, Afd Pharmacology, Sub Onderwijsinstituut Farmacie, Groningen Institute for Evolutionary Life Sciences, and Adult Psychiatry
- Subjects
0301 basic medicine ,Monoamines ,Impulsivity ,DEFICIT HYPERACTIVITY DISORDER ,microdialysis ,Microdialysis ,RAPHE SEROTONIN NEURONS ,Nucleus accumbens ,FREELY-MOVING RATS ,Prefrontal cortex ,03 medical and health sciences ,BRAIN-STIMULATION REWARD ,0302 clinical medicine ,monoamines ,medicine ,Eltoprazine ,5-HT1A/1B-receptor ,eltoprazine ,Amphetamine ,SIGNAL REACTION-TIME ,Pharmacology ,prefrontal cortex ,ENHANCES COCAINE REINFORCEMENT ,Ventral tegmental area ,VENTRAL TEGMENTAL AREA ,030104 developmental biology ,medicine.anatomical_structure ,5-HT1A RECEPTOR ,Brain stimulation ,LOCUS-COERULEUS ,Brain stimulation reward ,Orbitofrontal cortex ,medicine.symptom ,Psychology ,Neuroscience ,030217 neurology & neurosurgery ,5-HYDROXYTRYPTAMINE(1A) RECEPTOR ACTIVATION ,psychological phenomena and processes ,medicine.drug - Abstract
The 5-HT1A/1B-receptor agonist eltoprazine has a behavioral drug signature that resembles that of a variety of psychostimulant drugs, despite the differences in receptor binding profile. These psychostimulants are effective in treating impulsivity disorders, most likely because they increase norepinephrine (NE) and dopamine (DA) levels in the prefrontal cortex. Both amphetamine and methylphenidate, however, also increase dopamine levels in the nucleus accumbens (NAc), which has a significant role in motivation, pleasure, and reward.How eltoprazine affects monoamine release in the medial prefrontal cortex (mPFC), the orbitofrontal cortex (OFC), and the NAc is unknown. It is also unknown whether eltoprazine affects different forms of impulsivity and brain reward mechanisms.Therefore, in the present study, we investigate the effects of eltoprazine in rats in the following sequence: 1) the activity of the monoaminergic systems using in vivo microdialysis, 2) motivation for reward measured using the intracranial self-stimulation (ICSS) procedure, and finally, 3) "waiting" impulsivity in the delay-aversion task, and the "stopping" impulsivity in the stop-signal task.The microdialysis studies clearly showed that eltoprazine increased DA and NE release in both the mPFC and OFC, but only increased DA concentration in the NAc. In contrast, eltoprazine decreased 5-HT release in the mPFC and NAc (undetectable in the OFC). Remarkably, eltoprazine decreased impulsive choice, but increased impulsive action. Furthermore, brain stimulation was less rewarding following eltoprazine treatment. These results further support the long-standing hypothesis that "waiting" and "stopping" impulsivity are regulated by distoinct neural circuits, because 5-HT1A/1B-receptor activation decreases impulsive choice, but increases impulsive action.
- Published
- 2017
- Full Text
- View/download PDF
11. Bacterial Lipopolysaccharide Increases Serotonin Metabolism in Both Medial Prefrontal Cortex and Nucleus Accumbens in Male Wild Type Rats, but Not in Serotonin Transporter Knockout Rats
- Author
-
Korte-Bouws, Gerdien A H, van Heesch, Floor, Westphal, Koen G C, Ankersmit, Lisa M J, van Oosten, Edwin M, Güntürkün, Onur, Korte, S Mechiel, Afd Pharmacology, Pharmacology, Afd Pharmacology, and Pharmacology
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Microdialysis ,Knockout rat ,Synaptic cleft ,microdialysis ,nucleus accumbens ,Slc6a41 ,lcsh:Medicine ,lcsh:RS1-441 ,Pharmaceutical Science ,Nucleus accumbens ,Article ,lcsh:Pharmacy and materia medica ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Drug Discovery ,medicine ,Serotonin transporter ,biology ,Chemistry ,lcsh:R ,lipopolysaccharide ,serotonin transporter ,030104 developmental biology ,Monoamine neurotransmitter ,Endocrinology ,proinflammatory cytokines ,biology.protein ,Molecular Medicine ,Serotonin ,Reuptake inhibitor ,metabolism ,030217 neurology & neurosurgery ,medial prefrontal cortex - Abstract
It is well known that bacterial lipopolysaccharides (LPS) both increases proinflammatory cytokines and produces sickness behavior, including fatigue and anhedonia (i.e., the inability to experience pleasure). Previously, we have shown that intraperitoneally (i.p.) administered LPS increased extracellular monoamine metabolite levels in the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC), which was completely, or at least partly, prevented by pretreatment with a triple reuptake inhibitor that also blocks the serotonin (5-HT) transporter (SERT). This suggests indirectly, that LPS may enhance SERT transporter activity, and consequently, increase removal of 5-HT from the synaptic cleft, and increase metabolism of 5-HT. In the present study, we focus more specifically on the role of SERT in this increased metabolism by using rats, that differ in SERT expression. Therefore, the effects of an intraperitoneal LPS injection on extracellular concentrations of 5-HT and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) were investigated by in vivo microdialysis in the NAc and mPFC of wild type (SERT+/+), heterozygous (SERT+/&minus, ) and knockout (SERT&minus, /&minus, ) rats. Here, we show that LPS-induced 5-HIAA formation in male rats, is significantly increased in SERT+/+ rats in both the NAc and mPFC, whereas this increase is partly or totally abolished in SERT+/&minus, and SERT&minus, rats, respectively. Thus, the present study supports the hypothesis that systemic LPS in male rats increases SERT function and consequently enhances 5-HT uptake and metabolism in both the NAc and mPFC.
- Published
- 2018
12. Bacterial Lipopolysaccharide Increases Serotonin Metabolism in Both Medial Prefrontal Cortex and Nucleus Accumbens in Male Wild Type Rats, but Not in Serotonin Transporter Knockout Rats
- Author
-
Afd Pharmacology, Pharmacology, Korte-Bouws, Gerdien A H, van Heesch, Floor, Westphal, Koen G C, Ankersmit, Lisa M J, van Oosten, Edwin M, Güntürkün, Onur, Korte, S Mechiel, Afd Pharmacology, Pharmacology, Korte-Bouws, Gerdien A H, van Heesch, Floor, Westphal, Koen G C, Ankersmit, Lisa M J, van Oosten, Edwin M, Güntürkün, Onur, and Korte, S Mechiel
- Published
- 2018
13. Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening
- Author
-
Fedecostante, Michele, primary, Westphal, Koen G. C., additional, Buono, Michele F., additional, Sanchez Romero, Natalia, additional, Wilmer, Martijn J., additional, Kerkering, Janis, additional, Baptista, Pedro Miguel, additional, Hoenderop, Joost G., additional, and Masereeuw, Rosalinde, additional
- Published
- 2018
- Full Text
- View/download PDF
14. The 5-HT1A/1B-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and 'waiting' impulsivity, but increases 'stopping' impulsivity
- Author
-
Pharmacology, Afd Pharmacology, Sub Onderwijsinstituut Farmacie, Korte, S Mechiel, Prins, Jolanda, Van den Bergh, Filip S, Oosting, Ronald S, Dupree, Rudy, Korte-Bouws, Gerdien A H, Westphal, Koen G C, Olivier, Berend, Denys, Damiaan A, Garland, Alexis, Güntürkün, Onur, Pharmacology, Afd Pharmacology, Sub Onderwijsinstituut Farmacie, Korte, S Mechiel, Prins, Jolanda, Van den Bergh, Filip S, Oosting, Ronald S, Dupree, Rudy, Korte-Bouws, Gerdien A H, Westphal, Koen G C, Olivier, Berend, Denys, Damiaan A, Garland, Alexis, and Güntürkün, Onur
- Published
- 2017
15. Lipopolysaccharide increases degradation of central monoamines: An in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice
- Author
-
Van Heesch, Floor, Prins, Jolanda, Konsman, Jan Pieter, Korte-Bouws, Gerdien A H, Westphal, Koen G C, Rybka, Joanna, Olivier, Berend, Kraneveld, Aletta D., Korte, S. Mechiel, Sub BasicPharmacology&Psychopharmacology, UIPS - Utrecht Institute for Pharmaceutical Sciences, Sub Immunopharmacology, Sub General Pharmacology, Pharmacology, Sub BasicPharmacology&Psychopharmacology, UIPS - Utrecht Institute for Pharmaceutical Sciences, Sub Immunopharmacology, Sub General Pharmacology, and Pharmacology
- Subjects
Lipopolysaccharides ,Male ,medicine.medical_specialty ,Microdialysis ,Prefrontal Cortex ,Lipopolysaccharide ,Nucleus accumbens ,Plasma Membrane Neurotransmitter Transport Proteins ,Nucleus Accumbens ,Reuptake ,Mice ,Dopamine ,Internal medicine ,medicine ,Animals ,Biogenic Monoamines ,Triple reuptake inhibitor ,Prefrontal cortex ,Dopamine transporter ,Pharmacology ,Aza Compounds ,biology ,Chemistry ,Norepinephrine transporter ,Serotonin transporter ,Biological Transport ,Bridged Bicyclo Compounds, Heterocyclic ,Mice, Inbred C57BL ,Monoamine neurotransmitter ,Endocrinology ,nervous system ,biology.protein ,Brain stimulation reward ,lipids (amino acids, peptides, and proteins) ,Extracellular Space ,medicine.drug - Abstract
Peripheral administration of lipopolysaccharide (LPS) in rodents induces anhedonia, i.e. the inability to experience pleasure. Recently, we reported that serotonin transporter (SERT) function is required for LPS-induced anhedonia. Less is known about the effect of LPS on the biological activity of dopamine transporters (DAT) and norepinephrine transporters (NET). Therefore, in vivo microdialysis was performed in the nucleus accumbens and medial prefrontal cortex of C57BL6/J mice exposed to saline or LPS (133 μg/kg i.p.). To investigate the possible involvement of different monoamine transporters, the triple reuptake inhibitor DOV 216,303 or saline was i.p. injected 30 min before the saline/LPS injection. The dose of LPS, shown to decrease responding for brain stimulation reward in mice, significantly increased extracellular levels of monoamine metabolites (5-HIAA, DOPAC and HVA) in the nucleus accumbens and medial prefrontal cortex. Remarkably, DOV 216,303 abolished LPS-induced DOPAC and HVA formation in the nucleus accumbens, suggesting that LPS increases DAT activity in this brain area. DOV 216,303 also inhibited LPS-induced DOPAC and HVA formation in the medial prefrontal cortex. Since DAT density is very low in this brain structure, reuptake of DA predominantly takes place via NET, suggesting that LPS increases DAT and NET activity in the medial prefrontal cortex. Furthermore, DOV 216,303 pretreatment prevented LPS-induced 5-HIAA formation only in the medial prefrontal cortex, indicating that LPS increases prefrontal SERT activity. In conclusion, the present findings suggest that peripheral LPS increases DAT activity in the nucleus accumbens and increases NET and SERT activity in the medial prefrontal cortex of mice.
- Published
- 2014
16. The many different faces of major depression: it is time for personalized medicine
- Author
-
Korte, S Mechiel, Prins, Jolanda, Krajnc, Anne M, Hendriksen, Hendrikus, Oosting, Ronald S, Westphal, Koen G, Korte-Bouws, Gerdien A H, Olivier, Berend, Korte, S Mechiel, Prins, Jolanda, Krajnc, Anne M, Hendriksen, Hendrikus, Oosting, Ronald S, Westphal, Koen G, Korte-Bouws, Gerdien A H, and Olivier, Berend
- Abstract
First line antidepressants are the so-called SSRIs (selective serotonin reuptake inhibitors), e.g. fluvoxamine, fluoxetine, sertraline, paroxetine and escitalopram. Unfortunately, these drugs mostly do not provide full symptom relief and have a slow onset of action. Therefore other antidepressants are also being prescribed that inhibit the reuptake of norepinephrine (e.g. reboxetine, desipramine) or the reuptake of both serotonin (5-HT) and norepinephrine (e.g. venlafaxine, duloxetine, milnacipran). Nevertheless, many patients encounter residual symptoms such as impaired pleasure, impaired motivation, and lack of energy. It is hypothesized that an impaired brain reward system may underlie these residual symptoms. In agreement, there is some evidence that reuptake inhibitors of both norepinephrine and dopamine (e.g. methylphenidate, bupropion, nomifensine) affect these residual symptoms. In the pipeline are new drugs that block all three monoamine transporters for the reuptake of 5-HT, norepinephrine and dopamine, the so-called triple reuptake inhibitors (TRI). The working mechanisms of the above-mentioned antidepressants are discussed, and it is speculated whether depressed patients with different symptoms, sometimes even opposite ones due to atypical or melancholic features, can be matched with the different drug treatments available. In other words, is personalized medicine for major depression an option in the near future?
- Published
- 2015
17. The many different faces of major depression: it is time for personalized medicine
- Author
-
Pharmacology, Sub BasicPharmacology&Psychopharmacology, Sub General Pharmacology, Sub Immunopharmacology, Sub Onderwijsinstituut Farmacie, Korte, S Mechiel, Prins, Jolanda, Krajnc, Anne M, Hendriksen, Hendrikus, Oosting, Ronald S, Westphal, Koen G, Korte-Bouws, Gerdien A H, Olivier, Berend, Pharmacology, Sub BasicPharmacology&Psychopharmacology, Sub General Pharmacology, Sub Immunopharmacology, Sub Onderwijsinstituut Farmacie, Korte, S Mechiel, Prins, Jolanda, Krajnc, Anne M, Hendriksen, Hendrikus, Oosting, Ronald S, Westphal, Koen G, Korte-Bouws, Gerdien A H, and Olivier, Berend
- Published
- 2015
18. Lipopolysaccharide increases degradation of central monoamines: An in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice
- Author
-
Sub BasicPharmacology&Psychopharmacology, UIPS - Utrecht Institute for Pharmaceutical Sciences, Sub Immunopharmacology, Sub General Pharmacology, Pharmacology, Van Heesch, Floor, Prins, Jolanda, Konsman, Jan Pieter, Korte-Bouws, Gerdien A H, Westphal, Koen G C, Rybka, Joanna, Olivier, Berend, Kraneveld, Aletta D., Korte, S. Mechiel, Sub BasicPharmacology&Psychopharmacology, UIPS - Utrecht Institute for Pharmaceutical Sciences, Sub Immunopharmacology, Sub General Pharmacology, Pharmacology, Van Heesch, Floor, Prins, Jolanda, Konsman, Jan Pieter, Korte-Bouws, Gerdien A H, Westphal, Koen G C, Rybka, Joanna, Olivier, Berend, Kraneveld, Aletta D., and Korte, S. Mechiel
- Published
- 2014
19. Towards a bioengineered kidney: recellularization strategies for decellularized native kidney scaffolds.
- Author
-
Fedecostante, Michele, Onciu, Oana G., Westphal, Koen G. C., and Masereeuw, Rosalinde
- Published
- 2017
- Full Text
- View/download PDF
20. The Novel Triple Reuptake Inhibitor JZAD-IV-22 Exhibits an Antidepressant Pharmacological Profile without Locomotor Stimulant or Sensitization Properties
- Author
-
Caldarone, Barbara J., primary, Paterson, Neil E., additional, Zhou, Jia, additional, Brunner, Daniela, additional, Kozikowski, Alan P., additional, Westphal, Koen G. C., additional, Korte-Bouws, Gerdien A. H., additional, Prins, Jolanda, additional, Korte, S. Mechiel, additional, Olivier, Berend, additional, and Ghavami, Afshin, additional
- Published
- 2010
- Full Text
- View/download PDF
21. Reversal of Startle Gating Deficits in Transgenic Mice Overexpressing Corticotropin-Releasing Factor by Antipsychotic Drugs
- Author
-
Dirks, Anneloes, primary, Groenink, Lucianne, additional, Westphal, Koen G C, additional, Olivier, Jocelien D A, additional, Verdouw, P Monika, additional, van der Gugten, Jan, additional, Geyer, Mark A, additional, and Olivier, Berend, additional
- Published
- 2003
- Full Text
- View/download PDF
22. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning.
- Author
-
Wen-Sung Lai, Bin Xu, Westphal, Koen G. C., Paterlini, Marta, Olivier, Berend, Pavlidis, Paul, Karayiorgou, Maria, and Gogos, Joseph A.
- Subjects
SHORT-term memory ,SCHIZOPHRENIA ,CHEMICAL reactions ,PREFRONTAL cortex ,FRONTAL lobe ,NERVOUS system ,LABORATORY mice - Abstract
There is accumulating evidence that AKT signaling plays a role in the pathogenesis of schizophrenia. We asked whether Akt1 deficiency in mice results in structural and functional abnormalities in prefrontal cortex (PFC). Exploratory transcriptional profiling revealed concerted alterations in the expression of PFC genes controlling synaptic function, neuronal development, myelination, and actin polymerization, and follow-up ultrastructural analysis identified consistent changes in the dendritic architecture of pyramidal neurons. Behavioral analysis indicated that Akt1-mutant mice have normal acquisition of a PFC-dependent cognitive task but abnormal working memory retention under neurochemical challenge of three distinct neurotransmitter systems. Thus, Akt1 deficiency creates a context permissive for gene-gene and gene-environment interactions that modulate PFC functioning and contribute to the disease risk associated with this locus, the severity of the clinical syndrome, or both. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
23. Combination of Testosterone and Vardenafil Increases Female Sexual Functioning in Sub-Primed Rats.
- Author
-
Snoeren, Eelke M. S., Bovens, Astrid, Refsgaard, Louise K., Westphal, Koen G. C., Waldinger, Marcel D., Olivier, Berend, and Oosting, Ronald S.
- Subjects
- *
TESTOSTERONE , *SEXUAL desire disorders , *WOMEN'S sexual behavior , *THERAPEUTICS , *RATS - Abstract
Hypoactive sexual desire disorder (HSDD) is a common problem in women and may have a negative impact on quality of life. A recent clinical study shows an increase in sexual drive of HSDD women after cotreatment of testosterone and vardenafil (phosphodiesterase type 5 inhibitor). In this study, we investigated the effect of testosterone and vardenafil on sexual activity in female rats. Proceptive (darts and hops), receptive (lordosis), and paced-mating (percentages after exits and contact-return latencies) behaviors were quantified. Ovariectomized female rats, sub-primed with only estradiol and fully primed with estradiol and progesterone, were tested in a paced-mating sex test and sexual behaviors were quantified. The sub-primed rats are thought to model HSDD. The effect of testosterone (100 and 300 µg, subcutaneous [SC]) and vardenafil (10 mg/kg, per os [PO]) alone and testosterone (300 µg, SC) in combination with vardenafil (3 and 10 mg/kg, PO) were tested. We also studied the effects of testosterone (300 µg, SC) + intracerebroventricular (ICV) injections of vardenafil (25 and 50 µg) on sexual activity. No effect of testosterone and vardenafil alone was found, but cotreatment of testosterone and vardenafil (PO) caused a significant increase in proceptive and receptive behavior in the sub-primed female rats. Testosterone and vardenafil did not affect fully primed females. ICV administration of vardenafil combined with systemic testosterone, on the other hand, had no effect on sexual activity in both sub-primed and fully primed female rats. We conclude that cotreatment of subcutaneous testosterone and oral vardenafil increase sexual activity in sub-primed female rats. Our data supports the human finding that combination treatment of testosterone and vardenafil could be used as a new treatment for women with HSDD. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
24. Synthesis and Evaluation of Polymyxins Bearing Reductively Labile Disulfide-Linked Lipids.
- Author
-
Slingerland CJ, Wesseling CMJ, Innocenti P, Westphal KGC, Masereeuw R, and Martin NI
- Subjects
- Humans, Polymyxins pharmacology, Disulfides pharmacology
- Abstract
Polymyxins are a class of lipopeptide anti-infective agents with potent and specific activity against Gram-negative bacteria. While toxicity concerns associated with polymyxin B and E (colistin) have historically limited their clinical application, today they are increasingly used as last-resort antibiotics given the rise of multidrug-resistant Gram-negative pathogens. The adverse side effects of polymyxins are well known, particularly as related to their nephrotoxicity. Here, we describe the synthesis and evaluation of a novel series of polymyxin analogues, aimed at reducing their nephrotoxic effects. Using a semisynthetic approach, we explored modifications of the exocyclic part of the polymyxin scaffold, namely, the terminal amino acid and lipophilic tail. By incorporating a reductively labile disulfide linkage in the lipid tail, we obtained novel polymyxins that exhibit potent antibacterial activity on par with polymyxin B but with reduced toxicity toward human renal proximal tubular epithelial cells.
- Published
- 2022
- Full Text
- View/download PDF
25. Bacterial Lipopolysaccharide Increases Serotonin Metabolism in Both Medial Prefrontal Cortex and Nucleus Accumbens in Male Wild Type Rats, but Not in Serotonin Transporter Knockout Rats.
- Author
-
Korte-Bouws GAH, van Heesch F, Westphal KGC, Ankersmit LMJ, van Oosten EM, Güntürkün O, and Korte SM
- Abstract
It is well known that bacterial lipopolysaccharides (LPS) both increases proinflammatory cytokines and produces sickness behavior, including fatigue and anhedonia (i.e., the inability to experience pleasure). Previously, we have shown that intraperitoneally (i.p.) administered LPS increased extracellular monoamine metabolite levels in the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC), which was completely, or at least partly, prevented by pretreatment with a triple reuptake inhibitor that also blocks the serotonin (5-HT) transporter (SERT). This suggests indirectly, that LPS may enhance SERT transporter activity, and consequently, increase removal of 5-HT from the synaptic cleft, and increase metabolism of 5-HT. In the present study, we focus more specifically on the role of SERT in this increased metabolism by using rats, that differ in SERT expression. Therefore, the effects of an intraperitoneal LPS injection on extracellular concentrations of 5-HT and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) were investigated by in vivo microdialysis in the NAc and mPFC of wild type (SERT
+/+ ), heterozygous (SERT+/− ) and knockout (SERT−/− ) rats. Here, we show that LPS-induced 5-HIAA formation in male rats, is significantly increased in SERT+/+ rats in both the NAc and mPFC, whereas this increase is partly or totally abolished in SERT+/− and SERT−/− rats, respectively. Thus, the present study supports the hypothesis that systemic LPS in male rats increases SERT function and consequently enhances 5-HT uptake and metabolism in both the NAc and mPFC.- Published
- 2018
- Full Text
- View/download PDF
26. Serotonin release in the caudal nidopallium of adult laying hens genetically selected for high and low feather pecking behavior: an in vivo microdialysis study.
- Author
-
Kops MS, Kjaer JB, Güntürkün O, Westphal KG, Korte-Bouws GA, Olivier B, Bolhuis JE, and Korte SM
- Subjects
- Animals, Behavior, Animal drug effects, Blood Chemical Analysis methods, Brain blood supply, Brain drug effects, Female, Fenfluramine pharmacology, Hydroxyindoleacetic Acid blood, Microdialysis, Serotonin Agents pharmacology, Species Specificity, Tryptophan blood, Behavior, Animal physiology, Brain physiology, Chickens physiology, Feathers, Serotonin blood
- Abstract
Severe feather pecking (FP) is a detrimental behavior causing welfare problems in laying hens. Divergent genetic selection for FP in White Leghorns resulted in strong differences in FP incidences between lines. More recently, it was shown that the high FP (HFP) birds have increased locomotor activity as compared to hens of the low FP (LFP) line, but whether these lines differ in central serotonin (5-hydroxytryptamine, 5-HT) release is unknown. We compared baseline release levels of central 5-HT, and the metabolite 5-HIAA in the limbic and prefrontal subcomponents of the caudal nidopallium by in vivo microdialysis in adult HFP and LFP laying hens from the ninth generation of selection. A single subcutaneous d-fenfluramine injection (0.5 mg/kg) was given to release neuronal serotonin in order to investigate presynaptic storage capacity. The present study shows that HFP hens had higher baseline levels of 5-HT in the caudal nidopallium as compared to LFP laying hens. Remarkably, no differences in plasma tryptophan levels (precursor of 5-HT) between the lines were observed. d-fenfluramine increased 5-HT levels in both lines similarly indirectly suggesting that presynaptic storage capacity was the same. The present study shows that HFP hens release more 5-HT under baseline conditions in the caudal nidopallium as compared to the LFP birds. This suggests that HFP hens are characterized by a higher tonic 5-HT release., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
27. Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice.
- Author
-
van Heesch F, Prins J, Konsman JP, Korte-Bouws GA, Westphal KG, Rybka J, Olivier B, Kraneveld AD, and Korte SM
- Subjects
- Animals, Aza Compounds pharmacology, Biological Transport drug effects, Bridged Bicyclo Compounds, Heterocyclic pharmacology, Extracellular Space drug effects, Extracellular Space metabolism, Male, Mice, Mice, Inbred C57BL, Nucleus Accumbens cytology, Plasma Membrane Neurotransmitter Transport Proteins antagonists & inhibitors, Prefrontal Cortex cytology, Biogenic Monoamines metabolism, Lipopolysaccharides pharmacology, Microdialysis, Nucleus Accumbens drug effects, Nucleus Accumbens metabolism, Prefrontal Cortex drug effects, Prefrontal Cortex metabolism
- Abstract
Peripheral administration of lipopolysaccharide (LPS) in rodents induces anhedonia, i.e. the inability to experience pleasure. Recently, we reported that serotonin transporter (SERT) function is required for LPS-induced anhedonia. Less is known about the effect of LPS on the biological activity of dopamine transporters (DAT) and norepinephrine transporters (NET). Therefore, in vivo microdialysis was performed in the nucleus accumbens and medial prefrontal cortex of C57BL6/J mice exposed to saline or LPS (133 µg/kg i.p.). To investigate the possible involvement of different monoamine transporters, the triple reuptake inhibitor DOV 216,303 or saline was i.p. injected 30 min before the saline/LPS injection. The dose of LPS, shown to decrease responding for brain stimulation reward in mice, significantly increased extracellular levels of monoamine metabolites (5-HIAA, DOPAC and HVA) in the nucleus accumbens and medial prefrontal cortex. Remarkably, DOV 216,303 abolished LPS-induced DOPAC and HVA formation in the nucleus accumbens, suggesting that LPS increases DAT activity in this brain area. DOV 216,303 also inhibited LPS-induced DOPAC and HVA formation in the medial prefrontal cortex. Since DAT density is very low in this brain structure, reuptake of DA predominantly takes place via NET, suggesting that LPS increases DAT and NET activity in the medial prefrontal cortex. Furthermore, DOV 216,303 pretreatment prevented LPS-induced 5-HIAA formation only in the medial prefrontal cortex, indicating that LPS increases prefrontal SERT activity. In conclusion, the present findings suggest that peripheral LPS increases DAT activity in the nucleus accumbens and increases NET and SERT activity in the medial prefrontal cortex of mice., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
28. Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice.
- Author
-
van Heesch F, Prins J, Korte-Bouws GA, Westphal KG, Lemstra S, Olivier B, Kraneveld AD, and Korte SM
- Subjects
- 3,4-Dihydroxyphenylacetic Acid metabolism, Affect drug effects, Animals, Body Weight drug effects, Electric Stimulation, Homovanillic Acid metabolism, Hydroxyindoleacetic Acid metabolism, Male, Mice, Mice, Inbred C57BL, Microdialysis, Nucleus Accumbens drug effects, Recombinant Proteins metabolism, Brain physiology, Dopamine metabolism, Nucleus Accumbens metabolism, Reward, Serotonin metabolism, Tumor Necrosis Factor-alpha pharmacology
- Abstract
Many patients with chronic inflammatory disorders have an abnormal high prevalence of major depression accompanied by elevated levels of tumor necrosis factor-α (TNF-α). We hypothesize that systemic TNF-α increases brain monoamine metabolism, which might induce anhedonia (i.e. a core symptom of major depression). The effect of an intraperitoneal TNF-α injection on extracellular monoamine and metabolite concentrations was investigated by in vivo microdialysis in the nucleus accumbens (NAc) of C57BL/6 mice. In another group, the effects of TNF-α on body weight and intracranial self-stimulation (ICSS) thresholds were measured. TNF-α reduced body weight and increased ICSS thresholds, suggesting a state of anhedonia. TNF-α did not affect serotonin levels, but increased its metabolite 5-HIAA in the NAc. Remarkably, TNF-α also increased the dopamine metabolite HVA, without affecting dopamine levels itself. These data concur with earlier findings that pro-inflammatory cytokines enhance serotonin transporter activity, and possibly also dopamine transporter activity in the brain. However, more research is needed to understand the precise molecular mechanisms by which TNF-α increases transporter activity and anhedonia., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
29. Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats: an intracranial self-stimulation study.
- Author
-
van Heesch F, Prins J, Konsman JP, Westphal KGC, Olivier B, Kraneveld AD, and Korte SM
- Subjects
- Analysis of Variance, Anhedonia physiology, Animals, Animals, Genetically Modified, Area Under Curve, Bacterial Toxins pharmacology, Body Weight drug effects, Brain physiology, Cytokines pharmacology, Enterotoxins pharmacology, Escherichia coli Proteins, Gene Deletion, Male, Rats, Self Stimulation, Anhedonia drug effects, Lipopolysaccharides pharmacology, Serotonin Plasma Membrane Transport Proteins genetics, Serotonin Plasma Membrane Transport Proteins physiology
- Abstract
A growing body of evidence suggests that pro-inflammatory cytokines contribute to the pathogenesis of depression. Previously, it has been shown that cytokines (e.g. interferon-α therapy) induce major depression in humans. In addition, administration of the cytokine-inducer lipopolysaccharide (LPS) provokes anhedonia (i.e. the inability to experience pleasure) in rodents. Furthermore, serum pro-inflammatory cytokine levels are increased in depressed patients. Nevertheless, the etiology of cytokine-induced depression is largely unknown. Previously, it has been shown that selective serotonin re-uptake inhibitors decrease serum pro-inflammatory cytokine levels and that pro-inflammatory cytokines increase activity of the serotonin transporter (SERT). The purpose of this study was to explore the effect of partial and complete lack of the SERT in LPS-induced anhedonia assessed in the intracranial self-stimulation (ICSS) paradigm. A single intraperitoneal injection of LPS was used to induce a pro-inflammatory immune response in male serotonin transporter wild type (SERT(+/+)), heterozygous (SERT(+/-)) and knockout (SERT(-/-)) rats. Body weight and ICSS thresholds were measured daily. Although LPS reduced body weight in all genotypes, loss of body weight was less pronounced in SERT(-/-) compared to SERT(+/+) rats. Remarkably, LPS-induced anhedonia was totally abolished in SERT(-/-) rats and as expected was still present in SERT(+/+) and to a lesser extent in SERT(+/-) rats. Therefore, it is concluded that an intact SERT function is needed for pro-inflammatory cytokine-induced anhedonia and weight loss in rats., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
30. Celecoxib delays cognitive decline in an animal model of neurodegeneration.
- Author
-
Borre Y, Lemstra S, Westphal KG, Morgan ME, Olivier B, and Oosting RS
- Subjects
- Analysis of Variance, Animals, Celecoxib, Cytokines metabolism, Disease Models, Animal, Escape Reaction drug effects, Exploratory Behavior drug effects, Flow Cytometry, Male, Olfactory Bulb injuries, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Reaction Time drug effects, Time Factors, Cognition Disorders drug therapy, Cognition Disorders etiology, Cyclooxygenase 2 Inhibitors pharmacology, Neurodegenerative Diseases complications, Pyrazoles pharmacology, Sulfonamides pharmacology
- Abstract
Cyclooxygenase-2 (COX-2) is thought to play a role in the pathogenesis of various neurodegenerative disorders. However, clinical trials with COX-2 inhibitors have yielded contradictory results. In the present study we investigated whether COX-2 plays a role in the behavioral and cognitive impairments seen in olfactory bulbectomized rats. These impairments arise from neurodegenerative processes. First, we determined the time course of the OBX-induced behavioral (hyperactivity) and cognitive changes (fear memory) and how these correlate with changes in COX-2 mRNA expression in hippocampus. This experiment showed that the major impairments in behavior and cognition developed between Days 3 and 14 after OBX surgery, which correlated with changes in mRNA levels of COX-2, which increased at Days 7 and 14 after surgery but not anymore at day 28. In a subsequent experiment, rats were treated, starting two days before surgery, with the COX-2 inhibitor celecoxib (10 mg/kg, dissolved in drinking water) for 4 weeks. OBX-induced hyperactivity in the open field was normalized after 2 weeks of celecoxib treatment, but not longer after 4 weeks. Celecoxib partly rescued fear learning and memory deficits without affecting spatial memory. The effects of celecoxib on fear memory lasted up to 1 week posttreatment, but disappeared thereafter. Our results show that COX-2 plays a limited role (both in magnitude and time) in the development of the OBX syndrome., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
31. Re-exposure and environmental enrichment reveal NPY-Y1 as a possible target for post-traumatic stress disorder.
- Author
-
Hendriksen H, Bink DI, Daniels EG, Pandit R, Piriou C, Slieker R, Westphal KG, Olivier B, and Oosting RS
- Subjects
- Animals, Behavior, Animal drug effects, Disease Susceptibility psychology, Exploratory Behavior drug effects, Gene Expression Regulation drug effects, Male, Molecular Targeted Therapy, Nerve Tissue Proteins genetics, Nerve Tissue Proteins metabolism, Neuropeptide Y analogs & derivatives, Neuropeptide Y genetics, Neuropeptide Y therapeutic use, Neurotransmitter Agents therapeutic use, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Receptors, Corticotropin-Releasing Hormone genetics, Receptors, Corticotropin-Releasing Hormone metabolism, Receptors, G-Protein-Coupled agonists, Receptors, G-Protein-Coupled genetics, Receptors, Kainic Acid antagonists & inhibitors, Receptors, Neuropeptide agonists, Receptors, Neuropeptide genetics, Stress Disorders, Post-Traumatic drug therapy, Stress Disorders, Post-Traumatic metabolism, Stress Disorders, Post-Traumatic psychology, Amygdala metabolism, Disease Models, Animal, Neurons metabolism, Neuropeptide Y metabolism, Receptors, G-Protein-Coupled metabolism, Receptors, Neuropeptide metabolism, Socioenvironmental Therapy, Stress Disorders, Post-Traumatic therapy
- Abstract
Exposure-based cognitive behavioral therapy in post-traumatic stress disorder (PTSD) patients relieves symptoms caused by fear association as well as symptoms that are not the result of associative learning. We used the inescapable foot shock model (IFS), an animal model for PTSD, to study the possible involvement of glutamate receptors, the corticotropin-releasing factor (CRF) system, and the neuropeptide Y (NPY) system in the reduction of stress sensitization following repeated re-exposure to the conditioning context. Starting one week after the IFS procedure, the rats were repeatedly re-exposed to the shock environment. Stress sensitivity was measured in a modified open field test (sudden silence was used as a stressor). Selected mRNAs (GluN1, -2A-C, GluA1-4, GluK1-5, CRF, CRF-R1, NPY, NPY-Y1) were quantified in the amygdala. Repeated re-exposure (RE) to the IFS context reduced both trauma-associated anxiety (to the IFS context) and the enhanced stress sensitivity (in the open field). Changes in glutamate receptor subunits (GluN1, GluN2A-B, GluA1, GluA4, GluK3, GluK4) were detected in the amygdala that were normalized by RE. However, infusion of the AMPA/kainate antagonist NBQX in the BLA (basolateral amygdala) did not improve the anxious behavior. RE normalized IFS-induced increases in CRF-R1 mRNA and increased NPY-Y1 mRNA expression in the amygdala. Previously, and repeated here, we showed that environmental enrichment (EE) enhances recovery from IFS. EE led to similar changes in CRF-R1 and NPY-Y1 expression as RE did. Importantly, administration of [Leu31, Pro34]-NPY (Y1 agonist) in the BLA normalized the enhanced sensitivity to stress after IFS. Our data suggest that the NPY-Y1 receptor in the amygdala may serve as a therapeutic target for the treatment of PTSD., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
32. Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats.
- Author
-
Hendriksen H, Meulendijks D, Douma TN, Bink DI, Breuer ME, Westphal KG, Olivier B, and Oosting RS
- Subjects
- Analysis of Variance, Animals, Avoidance Learning physiology, Body Weight drug effects, Body Weight physiology, Brain-Derived Neurotrophic Factor genetics, Brain-Derived Neurotrophic Factor metabolism, Disease Models, Animal, Exercise Therapy, Exploratory Behavior drug effects, Exploratory Behavior physiology, Indoles pharmacology, Indoles therapeutic use, Learning Disabilities etiology, Locomotion drug effects, Locomotion physiology, Maze Learning drug effects, Maze Learning physiology, Memory Disorders etiology, Olfactory Bulb drug effects, Olfactory Bulb injuries, Protein Kinase Inhibitors pharmacology, Protein Kinase Inhibitors therapeutic use, Pyrroles pharmacology, Pyrroles therapeutic use, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Recognition, Psychology physiology, Time Factors, Vascular Endothelial Growth Factor A genetics, Vascular Endothelial Growth Factor A metabolism, Depression therapy, Environment, Learning Disabilities therapy, Memory Disorders therapy, Olfactory Bulb physiopathology
- Abstract
Depression, especially in the elderly, is associated with poor cognitive functioning. Exercise has received much attention in the treatment for depression and also dementia. Here we studied the effect of an enriched environment combined with voluntary exercise (EE/VE) on the olfactory bulbectomized (OBX) rat. The OBX rat is hyperactive in an open field, which is normalized by chronic antidepressant treatment, and suffers from learning and memory impairments. Neurotrophic factors are thought to be involved in the antidepressant action of EE/VE. Hyperactivity and cognitive functioning (both hippocampal dependent and independent tasks) were investigated before and after EE/VE. We quantified hippocampal mRNA levels of the neurotrophic factors BDNF, VGF and VEGF. VEGF receptor (FLK-1) inhibition was achieved by i.c.v administration of the antagonist SU5416 during the period of EE/VE. OBX almost completely blocked fear memory acquired either 48 h or 28 days before surgery. EE/EV normalized OBX-induced hyperactivity in open field, while having no effect on the decrease in hippocampal dependent learning and memory. VEGF mRNA levels in hippocampus were significantly increased both in OBX and control rats following EE/VE. OBX reduced BDNF mRNA levels, but EE did not reverse this. Inhibition of the FLK-1 receptor did not suppress EE/VE induced normalization of the hyperactivity of the OBX rat. The lack of effect of EE/VE on cognitive parameters, while normalizing hyperactivity, suggests different neuronal mechanisms underlying OBX-induced behavioral changes. Since EE/VE still normalizes the OBX-induced hyperactivity while the FLK-1 receptor was blocked, we assume that VEGF is not obligatory for the antidepressant effect of EE/VE. This article is part of a Special Issue entitled 'Anxiety and Depression'., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
33. The autonomic stress-induced hyperthermia response is not enhanced by several anxiogenic drugs.
- Author
-
Houtepen LC, Peterse DP, Westphal KG, Olivier B, and Vinkers CH
- Subjects
- Animals, Body Temperature physiology, Fever physiopathology, Male, Motor Activity drug effects, Rats, Rats, Wistar, Telemetry methods, Autonomic Nervous System physiopathology, Body Temperature drug effects, Carbolines pharmacology, Piperazines pharmacology, Stress, Psychological physiopathology, Yohimbine pharmacology
- Abstract
While anxiety models are often based on locomotor activity responses, the stress-induced hyperthermia (SIH) paradigm uses the autonomic stress response by measuring body temperature. The effects of putative anxiogenic compounds in the SIH paradigm are inconclusive in mice and have not been examined in rats. Furthermore, it has been suggested that drug-induced effects on body temperature could be dependent on locomotor activity levels. Therefore, the effects of three anxiogenic substances, yohimbine (an α(2) receptor antagonist), mCPP (a 5HT(2C) receptor agonist) and FG-7142 (a GABA(A) receptor inverse agonist acting at the benzodiazepine site) on the stress-induced body temperature and locomotor activity response were studied in rats using novel cage stress. All anxiogenic compounds resulted in hypothermia. In contrast, FG-7142 and yohimbine increased locomotor activity levels, whereas mCPP reduced locomotor activity levels. The lack of an increased body temperature response of anxiogenic compounds indicates that the anxiogenic capacity of a drug does not necessarily yield increased autonomic stress responsivity. Moreover, the present study shows that a drug-induced decreased body temperature can be accompanied by increased locomotor activity, suggesting that both parameters represent independent parameters of the stress response., (2010. Published by Elsevier Inc.)
- Published
- 2011
- Full Text
- View/download PDF
34. Medial amygdala lesions differentially influence stress responsivity and sensorimotor gating in rats.
- Author
-
Vinkers CH, Bijlsma EY, Houtepen LC, Westphal KG, Veening JG, Groenink L, and Olivier B
- Subjects
- Acoustic Stimulation psychology, Amygdala anatomy & histology, Animals, Anxiety physiopathology, Body Temperature physiology, Exploratory Behavior physiology, Fever physiopathology, Male, Motor Activity physiology, Rats, Rats, Wistar, Reflex, Startle physiology, Amygdala physiology, Sensory Gating physiology, Stress, Physiological physiology
- Abstract
Background: The amygdala is involved in the coordination of stress but is also an important gatekeeper involved in the regulation of vigilance. The amygdala is structurally complex, consisting of several nuclei with specific functions in the affective response to environmental stimuli. There are indications that the medial amygdaloid nucleus may be a pivotal player in acute responses to emotional environmental stimuli., Methods: The present study therefore aimed to study the effects of bilateral electrolytic lesions of the medial amygdala on unconditioned anxiety-related behavior as well as a sensorimotor gating parameter (prepulse inhibition, PPI) in rats. Anxiety-related behavior was assessed with the use of stress-induced hyperthermia (SIH), light-enhanced startle (LES) and open field behavior., Results: Bilateral electrolytic lesions of the medial amygdala decreased the SIH response and anxiety-related open field behavior. In contrast, lesioned animals displayed augmented LES and disrupted PPI. No changes in basal locomotor activity, body temperature and acoustic startle were found between lesioned and sham animals., Conclusions: The present study suggests that the medial amygdala is an important player in response to acute environmental stimuli. Decreased unconditioned psychological stress responses were found, whereas LES was enhanced and sensorimotor processing was disrupted. However, considering the existing data on basolateral amygdala involvement in PPI and bed nucleus of the stria terminalis involvement in LES, local infusion studies into the MeA should be performed to further substantiate these findings., (Copyright (c) 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
35. Stress-induced hyperthermia is reduced by rapid-acting anxiolytic drugs independent of injection stress in rats.
- Author
-
Vinkers CH, de Jong NM, Kalkman CJ, Westphal KG, van Oorschot R, Olivier B, Korte SM, and Groenink L
- Subjects
- 8-Hydroxy-2-(di-n-propylamino)tetralin pharmacology, Animals, Body Temperature drug effects, Drug Interactions, Male, Midazolam therapeutic use, Motor Activity drug effects, Nicotine pharmacology, Nicotinic Agonists pharmacology, Rats, Rats, Wistar, Serotonin 5-HT1 Receptor Agonists, Telemetry, Anti-Anxiety Agents therapeutic use, Fever etiology, Fever prevention & control, Injections, Intravenous adverse effects, Stress, Psychological complications, Stress, Psychological prevention & control
- Abstract
Background: Stress-induced hyperthermia (SIH) is the transient rise in body temperature after encountering a stressor. The SIH response can be blocked by administration of various anxiolytic drugs prior to inducing stress. However, a drug injection involves handling and injection stress and therefore induces a SIH response itself. In the standard SIH test, drugs are therefore injected 60 min before stress induction to allow injection-induced hyperthermia to decline. This makes it difficult to study putative anxiolytic compounds with a short half-life. The present study therefore aimed to compare the effects of standard (stressful) and stress-free anxiolytic drug administration on the subsequent SIH response with a 10-minute injection-stressor interval., Methods: Anxiolytic drugs with short half-lives (midazolam, 8-OH-DPAT, nicotine) were injected subcutaneously in rats using either a stressful (manual injection) or stress-free injection (subcutaneous cannula) method 10 min before novel cage stress. Body temperature and locomotor activity were measured using telemetric transmitters., Results: Stressful and stress-free drug administration resulted in comparable drug effects on the stress-induced hyperthermia and locomotor responses in rats., Conclusion: The present study shows that both stressful and stress-free drug injection shortly before a stressor results in reproducible attenuation of the SIH response in rats. In rats, a short injection-stressor interval can therefore be applied using the SIH model, enabling the study of putative anxiolytic drugs with short half-lives.
- Published
- 2009
- Full Text
- View/download PDF
36. Stress-induced hyperthermia and infection-induced fever: two of a kind?
- Author
-
Vinkers CH, Groenink L, van Bogaert MJ, Westphal KG, Kalkman CJ, van Oorschot R, Oosting RS, Olivier B, and Korte SM
- Subjects
- Animals, Aspirin pharmacology, Diazepam pharmacology, Dose-Response Relationship, Drug, Electrodes, Implanted, Fever chemically induced, GABA Agonists pharmacology, GABA-A Receptor Agonists, Interleukin-1beta, Lipopolysaccharides pharmacology, Male, Mice, Mice, Inbred C57BL, Prostaglandin Antagonists pharmacology, Rats, Rats, Wistar, Telemetry, Fever etiology, Fever physiopathology, Infections complications, Infections physiopathology, Stress, Psychological complications, Stress, Psychological physiopathology
- Abstract
Stress exposure activates the autonomic nervous system and leads to a body temperature increase (stress-induced hyperthermia, SIH). On the other hand, an activation of the immune system in response to an infection leads to fever. Both processes increase body temperature, and the relation between SIH and infection-induced fever has been subject to debate. It is not clear whether SIH is a form of fever, or whether both processes are more or less distinct. We therefore examined the relation between SIH and infection-induced fever by looking at the effects of a GABA(A) receptor agonist (diazepam) and a prostaglandin-synthesis blocking drug (acetylsalicylic acid, aspirin) on both the SIH response and fever in rats and mice. The present study shows that the benzodiazepine diazepam but not the prostaglandin-synthesis blocking drug aspirin dose-dependently attenuated the SIH response in both rats and mice. In contrast, aspirin reduced both LPS- and IL-1beta induced fever, whereas diazepam had little effect on these fever states. Altogether, our findings support the hypothesis that stress-induced hyperthermia and infection-induced fever are two distinct processes mediated largely by different neurobiological mechanisms.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.